US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

(CSE:GDBY)

N/A UNCHANGED
Last Price Updated: 9:53 AM EDT, Aug 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GDBY

< Previous 1 2 Next >
News headline image
Goodbody Health Progress Update: Phlebotomy Services
Via ACCESSWIRE
News headline image
Goodbody Health Partners with Datar to Offer Innovative Cancer Screening
Via ACCESSWIRE
News headline image
Board Updates
Via ACCESSWIRE
News headline image
Goodbody Health Announces Cash Injection for Growth Through Divestment of Polish CBD Operations
Via ACCESSWIRE
News headline image
Board Update
Via ACCESSWIRE
News headline image
Goodbody Health Limited Publishes Financial Results Q3 2022
Via ACCESSWIRE
News headline image
Goodbody Health Limited (Previously: Goodbody Health Inc.) Director Transfer of Ordinary Shares
Via ACCESSWIRE
News headline image
Goodbody Health Inc. (Renamed: Goodbody Health Limited) Provides Shareholders Update on Completion of Continuation
Via ACCESSWIRE
News headline image
Goodbody Health Inc Publishes Half Year Financial Results Q2 2022
Via ACCESSWIRE
News headline image
Goodbody Health Inc. Provides Annual General and Special Meeting of Shareholders Update
Via ACCESSWIRE
News headline image
Goodbody Health Announces Annual General and Special Meeting of Shareholders
VANCOUVER, BC / ACCESSWIRE / July 14, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), announces that further to its news release dated June 10, 2022, the Company has... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health launches Genetic Risk Testing for Cancer and Cardiovascular Diseases
VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it is launching new genetic cancer tests to... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Granted Care Quality Commission Registration
VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that following its application for registration... 
From Goodbody Health Inc.
Via AccessWire
News headline image
AGM, Plan to De-List from the CSE, Redomicile to Guernsey, And Appointment of Peterhouse as Corporate Adviser
Aligns With Company's Substantial U.K. Presence and Supports Its Growth Strategy 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Announces the Launch of Its Core Health Diagnostic Check
VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, it has launched its core UK Health check... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Inc. Publishes Highest Quarterly Profit to Date in Q1 2022
VANCOUVER, BC / ACCESSWIRE / May 25, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce its highest comprehensive profit of £0.10m and... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Inc. Publishes 2021 Audited Financial Statements
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Subsidiary Granted UK Home Office Controlled Drugs Licence
VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that its subsidiary, PhytoVista Laboratories, has... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Products Included on FSA Novel Foods Register
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, following the UK Food Standard Agencies... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Confirms Strong 2021 Revenue Continuing into 2022
VANCOUVER, BC / ACCESSWIRE / March 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, the unaudited revenue figures for the year... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Announces Blood Testing Technology Roll Out
VANCOUVER, BC / ACCESSWIRE / March 8, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) (Goodbody Health" or the "Company") is pleased to announce that, following a pilot project using new technology... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Announces Normal Course Issuer Bid and Restricted Share Unit Plan
VANCOUVER, BC / ACCESSWIRE / March 4, 2022 / Goodbody Health Inc. (CSE:GDBY), (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce: (i) its intention to initiate a normal course... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Announces Moves up to OTCQB
VANCOUVER, BC / ACCESSWIRE / February 22, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it has moved up a tier from the over the... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Announces Opening of First Clinic in Canada
VANCOUVER, BC / ACCESSWIRE / February 18, 2022 / Goodbody Health Inc. (CSE:GDBY) (Goodbody Health" or the "Company") is pleased to announce that following its successful rollout of Goodbody testing... 
From Goodbody Health Inc.
Via AccessWire
Introduction of Innovative PCR-Based Detection Methods Surges Fueled by Pandemic and Other Diseases
Palm Beach, FL – February 18, 2022 – FinancialNewsMedia.com News Commentary – PCR testing and the COVID-19 diagnostic testing market has, unexpectantly, been growing at a substantial rate the past few... 
Via FinancialNewsMedia
Topics Intellectual Property
GOODBODY HEALTH ANNOUNCES FIRST CLINIC IN CANADA
Vancouver, BC – February 18, 2022 – Goodbody Health Inc. (CSE: GDBY) (Goodbody Health” or the “Company”) is pleased to announce that following its successful rollout of Goodbody testing clinics in the... 
Via FinancialNewsMedia
Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market
Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years.... 
Via FinancialNewsMedia
GOODBODY HEALTH ANNOUNCES BLOOD TESTING TRIAL SUCCESS
Vancouver, BC – February 16, 2022 – Goodbody Health Inc. (OTCPK: GDBYF) (CSE: GDBY) (Goodbody Health” or the “Company”) is pleased to announce the rollout of its plan to introduce blood testing through... 
Via FinancialNewsMedia
News headline image
Goodbody Health Announces Blood Testing Trial Success
VANCOUVER, BC / ACCESSWIRE / February 16, 2022 / Goodbody Health Inc. (CSE:GDBY) (Goodbody Health" or the "Company") is pleased to announce the rollout of its plan to introduce blood testing through... 
From Goodbody Health Inc.
Via AccessWire
News headline image
Goodbody Health Announces Extension of Scope of ISO 17025
VANCOUVER, BC / ACCESSWIRE / February 7, 2022 / Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased to announce its subsidiary Phytovista Laboratories has achieved another... 
From Goodbody Health Inc.
Via AccessWire
< Previous 1 2 Next >